Andrew Harris
Pediatric Hematology-Oncology · New York, NYNPI 1356546493
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $55,964 of the $85,384 with a category attached, or 65.5%. 13 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 31.6% of the total. Among pediatric hematology-oncology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 112 payments — averaging $762.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$27K
- Incyte Corporation$21K
- Sanofi$11K
- CSL Behring$10K
- Mesoblast, Inc.$4K
- AstraZeneca$4K
- plus $8K from 7 others
Across 85 payments — averaging $2475.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$101K
- Jazz Pharmaceuticals Inc.$53K
- Sanofi US Services Inc.$27K
- Mallinckrodt Enterprises LLC$10K
- Takeda Pharmaceuticals U.S.A., Inc.$8K
- AstraZeneca$5K
- plus $6K from 2 others
What the payments were for
- Consulting fees$55,96466%
- Speaking & faculty fees$6,5108%
- Travel & lodging$18,64422%
- Food & beverage$4,2675%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 29 | $26,966 |
| Incyte Corporation | 42 | $20,711 |
| Sanofi | 6 | $10,921 |
| CSL Behring | 9 | $10,246 |
| Mesoblast, Inc. | 2 | $4,443 |
| AstraZeneca | 6 | $4,054 |
| National Marrow Donor Program | 9 | $3,600 |
| Amgen | 1 | $2,790 |
| Janssen Scientific Affairs, LLC | 1 | $1,010 |
| Genentech USA, Inc. | 2 | $261 |
| Sobi, Inc | 2 | $235 |
| Novartis | 2 | $126 |
| Y-mabs Therapeutics, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$85,384 in reported general payments places this provider in the 90th percentile of 196 pediatric hematology-oncology providers in New York.
See all pediatric hematology-oncology providers in New York →
Other pediatric hematology-oncology in New York
- Sujit ShethNew York$359K
- Jaap Jan BoelensNew York$303K
- James BusselNew York$204K
- Saara KavianyNew York$144K
- Gary BrittenhamNew York$137K
- James FerraraNew York$118K
- John LevineNew York$98K
- Nai-Kong CheungNew York$86K
- Joseph OvedNew York$77K
- Catherine McGuinnNew York$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.